Pilot of a general practice-led intervention to increase national bowel cancer screening program participation

We are conducting a randomised controlled trial of a pilot intervention to increase the involvement of general practice (i.e., general practitioners (GPs), nurses, practice managers and other staff) in promoting the National Bowel Cancer Screening Program and ensuring patients undergo bowel cancer screening in line with clinical guidelines.

The study is aiming to recruit up to 100 general practices within four Primary Health Network (PHN) regions in New South Wales, Queensland and South Australia.

Participating general practices will complete two questionnaires, at baseline and study end, and if allocated to the intervention group be supported by a Clinical Trial Coordinator to implement strategies to facilitate bowel cancer screening within their practice. 

Eligibility

We are seeking participation from up to 100 general practices from the participating PHN
regions of Central and Eastern Sydney PHN, Brisbane South PHN, Gold Coast PHN and Adelaide PHN.

Inclusion criteria for general practices are:

  • Has at least two GPs (2 FTE) willing to participate in the trial.
  • Nominated Practice Champion who is willing and able to liaise with the Research
    Team
  • Uses Medical Director Or Best Practice software
  • Uses Pen CS, Polar or PrimarySense
  • Available over the trial period, September 2024 – May 2025
  • Windows 10 or higher, i5/i7 GB processing or willing to upgrade.
  • Has over 1000 active patients and sees minimum of 35 adult patients per day.

Exclusion criteria:

  • Shares a server with another practice.
  • Uses paper based medical records.
  • Does not share a data with the PHN. 

How to participate

To express interest in participating, please visit the following link (https://redcap.sydney.edu.au/redcap_v14.3.14/Surveys/invite_participants.php?pid=19369).

For more information on participation please email bowel@daffodilcentre.org

 

Ethics committee approval number: 2023/496